J. Safra Asset Management’s Gilead Sciences GILD Stock Holding History

J. Safra Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$34.7K	Sell	275 -34	-11%	-$4.48K	﹤0.01%	285
2026 Q1	$43.1K	Buy	309 +137	+80%	+$19.2K	﹤0.01%	266
2025 Q4	$21.1K	Buy	172 +161	+1,464%	+$19.6K	﹤0.01%	322
2025 Q3	$1.22K	Buy	11 +1	+10%	+$114	﹤0.01%	449
2025 Q2	$1.11K	Buy	10 +1	+11%	+$106	﹤0.01%	358
2025 Q1	$1.01K	Buy	9 +5	+125%	+$516	﹤0.01%	334
2024 Q4	$368	Buy	+4	New	+$360	﹤0.01%	331
2016 Q4	–	Sell	-285	Closed	-$23K	–	67
2016 Q3	$23K	Hold	285	–	–	0.04%	132
2016 Q2	$24K	Buy	+285	New	+$25.3K	0.04%	190

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

J. Safra Asset Management's GILD Position: Q2 2026 in Review

J. Safra Asset Management reduced its Gilead Sciences (GILD) stake by 11% in Q2 2026, selling an estimated $4.48K and leaving 275 shares worth $34.7K. The position accounts for ﹤0.01% of the portfolio, ranked #285.

J. Safra Asset Management first reported a position in GILD in Q2 2016 and has held it in 9 quarters since. The position peaked at $43.1K in Q1 2026. 2,293 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

J. Safra Asset Management held 275 shares of Gilead Sciences worth $34.7K as of Q2 2026.
J. Safra Asset Management sold 34 Gilead Sciences shares in Q2 2026, an estimated $4.48K.
Gilead Sciences made up ﹤0.01% of J. Safra Asset Management's portfolio in Q2 2026, its #285 holding.
J. Safra Asset Management first reported a position in Gilead Sciences in Q2 2016 and has held it in 9 quarters since.
J. Safra Asset Management's Gilead Sciences position peaked at $43.1K in Q1 2026.
2,293 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on J. Safra Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.